AI PRICE FORECAST
CME Stock Forecast & AI Price Prediction
CME Group · Financial Services · Financial Data & Stock Exchanges
CME live signal snapshot
Shares of CME were last at $315.87, up 2.19% on the day, trading 4.0% below its 52-week high of $329.16 and 44.7% above its 52-week low of $218.31. Our AI model's current call on CME is BUY, with 87% confidence. The short-term averages line up bullishly, and the price is holding above its 50-day line. Its one-month projection is about $327.36, a 3.6% move from the last price.
CME's 14-day RSI is 59.9 — healthy bullish momentum without being overextended. The MACD indicator sits over its signal line, and the histogram reading of 0.32 shows buying pressure building. The 50-day moving average ($284.53) sits 1.2% above the 200-day ($281.28) — a "golden cross" structure that typically supports the longer-term uptrend.
16 Wall Street analysts covering CME put the average price target at $317.06 (range $227.00–$367.00), implying 0.4% upside from the current price. The current recommendation trend leans bullish: 9 Buy/Strong Buy ratings vs 2 Sell/Strong Sell (and 6 Hold).
Live figures from real market data feeds, current as of the last site build. Open the interactive CME dashboard for numbers updated throughout today's session.
About CME Group
CME Group Inc. (CME) is a financial data & stock exchanges company in the financial services sector, headquartered in Chicago, IL, United States. CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It has a market value of about $113.1 billion and roughly 3,875 full-time employees. With a beta of 0.18, the stock has historically moved less than the overall market.
CME performance vs. the market
CME is up 15.7% so far in 2026, ahead of the S&P 500 (+11.4%) and ahead of the financial services sector fund XLF (+7.0%). Over the past 12 months the stock has gained 13.9%, 2.4 points better than the S&P 500. Its +13.6% move over the past month extends a +18.2% three-month run.
| Period | CME | Sector (XLF) | S&P 500 |
|---|---|---|---|
| 1 month | +13.6% | +7.0% | −2.3% |
| 3 months | +18.2% | +0.6% | −2.3% |
| Year to date | +15.7% | +7.0% | +11.4% |
| 1 year | +13.9% | +10.7% | +11.5% |
CME Group financials at a glance
CME Group's most recent quarter (ended Sep 30, 2026) brought in $1.7 billion of revenue and net income of $0 (a 0.0% net margin). Revenue was up 13.0% from the same quarter a year earlier. The stock trades at a price-to-earnings ratio of 25.9 on trailing earnings of $12.20 per share. Trailing free cash flow was $3.1 billion, and total debt equals 15% of shareholders' equity.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Sep 30, 2026 | $1.7B | $0 |
| Jun 30, 2026 | $1.7B | $0 |
| Mar 31, 2026 | $1.9B | $0 |
| Dec 31, 2025 | $1.6B | $1.2B |
CME vs. its peers
CME's +15.7% this year ranks ahead of 5 of the 5 big financial services names below. None of them has done better this year.
| Company | Price | YTD | P/E | AI verdict |
|---|---|---|---|---|
| CME Group (CME) | $315.87 | +15.7% | 25.9 | BUY |
| S&P Global (SPGI) | $475.11 | −3.9% | 28.4 | BUY |
| Intercontinental Exchange (ICE) | $180.59 | +11.5% | 24.6 | BUY |
| MSCI (MSCI) | $661.53 | +15.3% | 35.0 | BUY |
| Coinbase Global (COIN) | $136.27 | −39.7% | — | SELL |
| JPMorgan Chase (JPM) | $343.39 | +6.6% | 14.4 | BUY |
CME stock: common questions
What is the CME stock price target?
16 Wall Street analysts put the average 12-month target at $317.06, in a range of $227.00–$367.00, versus a recent price of $315.87. Stock Pulse 247's model projects about $327.36 over the next month.
Is CME a buy right now?
Our AI model currently rates CME a BUY at 87% confidence. Among analysts, 9 rate it Buy or Strong Buy, 6 Hold and 2 Sell. Neither is personal advice — weigh them with your own research and risk tolerance.
How has CME stock performed this year?
CME is up 15.7% so far in 2026, ahead of the S&P 500 (+11.4%) and ahead of the financial services sector fund XLF (+7.0%). Over the past 12 months the stock has gained 13.9%, 2.4 points better than the S&P 500. Its +13.6% move over the past month extends a +18.2% three-month run.
What is CME's 52-week high and low?
CME has traded between $218.31 and $329.16 over the past 52 weeks; at $315.87 it is 4.0% below its 52-week high of $329.16 and 44.7% above its 52-week low of $218.31.
What sector is CME in, and who are its peers?
CME is in the financial services sector (financial data & stock exchanges). Its largest peers on Stock Pulse 247 include S&P Global (SPGI), Intercontinental Exchange (ICE), MSCI (MSCI), Coinbase Global (COIN).
How accurate is the CME forecast?
It's a model estimate from price history, technical indicators and analyst targets, not a guarantee — no model predicts short-term moves reliably. Use it as one input alongside your own research.
How this works: the forecast combines CME's price history, momentum indicators (RSI, MACD, moving averages), volatility and analyst targets into one estimate. It's a model, not a guarantee.